Organization
Mediar Therapeutics
1 clinical trial
Clinical trial
MTX-463-I101: A Phase 1 Randomized, Double-Blind, Dose-Escalating Study to Assess the Safety, Tolerability, and Pharmacokinetics of MTX-463 in Healthy AdultsStatus: Recruiting, Estimated PCD: 2024-11-16